Overcome the limitation of hypoxia against photodynamic therapy to treat cancer cells by using perfluorocarbon nanodroplet for photosensitizer delivery
- 1 June 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 487 (3) , 483-487
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81202474, 81273464, 81473146)
This publication has 13 references indexed in Scilit:
- Ablation of Hypoxic Tumors with Dose-Equivalent Photothermal, but Not Photodynamic, Therapy Using a Nanostructured Porphyrin AssemblyACS Nano, 2013
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Impact of Tumor Hypoxia and Anemia on Radiation Therapy OutcomesThe Oncologist, 2002
- Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (Clinical pilot study in 40 patients)European Journal of Cardio-Thoracic Surgery, 2001
- Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular AspectsJNCI: Journal of the National Cancer Institute, 2001
- Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagusLasers in Surgery and Medicine, 2000
- Does Hyperbaric Oxygen Enhance the Effect of Photodynamic Therapy in Patients with Advanced Esophageal Carcinoma? A Clinical Pilot StudyEndoscopy, 2000
- Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat ColonPhotochemistry and Photobiology, 1999
- Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude miceEuropean Journal of Cancer and Clinical Oncology, 1991
- OXYGEN DEPENDENCY OF PHOTOCYTOTOXICITY WITH HAEMATOPORPHYRIN DERIVATIVEPhotochemistry and Photobiology, 1984